Related Experiment Video
Updated: Jan 26, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Management of cardiogenic shock in patients with acute coronary syndromes
Krishnaraj S Rathod1, Alexander Sirker2, Andreas Baumbach3
1Interventional Cardiology Specialist Registrar, Barts Interventional Group, Barts Heart Centre, Barts Health NHS Trust, London and Doctoral Research Fellow, NIHR Biomedical Research Centre at Barts, Barts Health NHS Trust and Queen Mary University of London, London.
Insights
Cardiogenic shock in acute coronary syndromes has a high mortality rate. Current treatments like mechanical support show limited evidence, necessitating further research and specialized care centers.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock is a significant complication of acute coronary syndromes.
- It is associated with a persistently high mortality rate despite advancements in treatment.
Purpose of the Study:
- To review current mechanical support options for cardiogenic shock.
- To assess the evidence and recent advances in managing cardiogenic shock.
- To identify areas for future research in high-risk patients.
Main Methods:
- Literature review of current treatments for cardiogenic shock.
- Assessment of evidence for intra-aortic balloon pumps, percutaneous ventricular assist devices, and extracorporeal membrane oxygenation.
- Discussion of recent advances and future research directions.
Main Results:
- Mechanical reperfusion with percutaneous coronary intervention has improved outcomes.
- Limited evidence supports the efficacy of other current treatments for cardiogenic shock.
- Need for further research into optimal management strategies.
Conclusions:
- Current mechanical support options for cardiogenic shock require more robust evidence.
- Coordinated, regionalized approaches with multidisciplinary care in tertiary shock centers are crucial.
- Future research should focus on improving outcomes for high-risk cardiogenic shock patients.
Abstract:
Cardiogenic shock remains a major problem affecting a large proportion of patients with acute coronary syndromes, with a persistent high mortality rate. Although mechanical reperfusion with percutaneous coronary intervention has improved outcomes following acute coronary syndromes, there is limited evidence supporting the other current treatments used to manage patients with cardiogenic shock (intra-aortic balloon pumps, percutaneous left ventricular assist devices and extracorporeal membrane oxygenation). This article looks at these options, assessing current evidence and recent advances. It also discusses areas that still require research to ensure there is improvement in these high-risk patients, such as coordinated regionalised approaches to cardiogenic shock management with multidisciplinary care provided in designated tertiary shock centres.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Related Concept Videos
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management